MSH|^~\&|SendAppName^2.16.840.1.114222.TBD^ISO|Sending-Facility^2.16.840.1.114222.TBD^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20140630120030.1234-0500||ORU^R01^ORU_R01|MESSAGE CONTROL ID|D|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~TB_MMG_V3.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||TB_TC_03^^^SendAppName&2.16.840.1.114222.nnnn&ISO||~^^^^^^S||19901201|M||2106-3^White^CDCREC|^^Atlanta^13^30329^^^^13089|||||||||||2135-2^Hispanic or Latino^CDCREC||||||||||||||||OBR|1||LTBI_TC_03^SendAppName^2.16.840.1.114222.TBD^ISO|68991-9^Epidemiologic Information^LN|||20171020111111|||||||||||||||20181122111111|||C||||||50258^Latent TB Infection^NNDOBX|1|CWE|78746-5^Country of Birth^LN||PHL^PHILIPPINES^ISO3166_1||||||FOBX|2|CWE|77983-5^Country of Usual Residence^LN||USA^UNITED STATES^ISO3166_1||||||FOBX|3|SN|77998-3^Age at Case Investigation^LN||^28|a^year [time]^UCUM|||||FOBX|4|CWE|77996-7^Pregnancy Status^LN||N^No^HL70136||||||FOBX|5|TS|77975-1^Diagnosis Date^LN||20171018||||||FOBX|6|CWE|77974-4^Hospitalized^LN||N^No^HL70136||||||FOBX|7|ST|74549-7^Person Reporting to CDC - Name^LN||Hut, Jaba||||||FOBX|8|ST|74547-1^Person Reporting to CDC - Email^LN||jhut@ga.dph,gov||||||FOBX|9|DT|77979-3^Case Investigation Start Date^LN||20171020||||||FOBX|10|CWE|77989-2^Transmission Mode^LN||416380006^Airborne transmission^SCT||||||FOBX|11|SN|77991-8^MMWR Week^LN||^40||||||FOBX|12|DT|77992-6^MMWR Year^LN||2017||||||FOBX|13|CWE|77966-0^Reporting State^LN||13^Georgia^FIPS5_2||||||FOBX|14|CWE|77967-8^Reporting County^LN||13089^DeKalb, GA^FIPS6_4||||||FOBX|15|CWE|77968-6^National Reporting Jurisdiction^LN||13^GA^FIPS5_2||||||FOBX|16|CWE|77990-0^Case Class Status Code^LN||410605003^Confirmed present^SCT||||||FOBX|17|CWE|77980-1^Case Outbreak Indicator^LN||N^No^HL70136||||||FOBX|18|ST|INV1107^TB State Case Number^PHINQUESTION||2017GALTBI99123||||||FOBX|19|CWE|DEM153^Detailed Race^PHINQUESTION||2036-2^Filipino^CDCREC||||||FOBX|20|CWE|DEM2003^US Born^PHINQUESTION||Y^Yes^HL70136||||||FOBX|21|CWE|INV1113^Primary Guardian(s) Country of Birth^PHINQUESTION||PHL^PHILIPPINES^ISO3166_1||||||FOBX|22|CWE|INV1116^Initial Reason for Evaluation^PHINQUESTION||PHC681^Contact investigation^CDCPHINVS||||||FOBX|23|CWE|76689-9^Birth Sex^LN||M^Male^HL70001||||||FOBX|24|CWE|INV1109^Previously Counted Case^PHINQUESTION||N^No^HL70136||||||FOBX|25|CWE|INV1112^Inside City Limits^PHINQUESTION||Y^Yes^HL70136||||||FOBX|26|CWE|INV1276^Occupation and Industry Category^PHINQUESTION||UNK^Unknown^NULLFL||||||FOBX|27|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|1|PHC2098^Diabetic at Diagnostic Evaluation^CDCPHINVS||||||FOBX|28|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|1|UNK^Unknown^NULLFL||||||FOBX|29|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|2|46177005^End-Stage Renal Disease^SCT||||||FOBX|30|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|2|N^No^HL70136||||||FOBX|31|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|3|86933000^Heavy Alcohol Use in the Past 12 Months^SCT||||||FOBX|32|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|3|N^No^HL70136||||||FOBX|33|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|4|161663000^Post-Organ Transplantation^SCT||||||FOBX|34|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|4|N^No^HL70136||||||FOBX|35|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|5|32911000^Homeless Ever^SCT||||||FOBX|36|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|5|Y^Yes^HL70136||||||FOBX|37|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|6|PHC1876^Homeless in the Past 12 Months^CDCPHINVS||||||FOBX|38|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|6|N^No^HL70136||||||FOBX|39|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|7|226034001^Injecting Drug Use in the Past 12 Months^SCT||||||FOBX|40|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|7|N^No^HL70136||||||FOBX|41|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|8|PHC1877^Noninjecting Drug Use in the Past 12 Months^CDCPHINVS||||||FOBX|42|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|8|Y^Yes^HL70136||||||FOBX|43|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|9|42665001^Resident of Long-Term Care Facility at Diagnositic Evaluation^SCT||||||FOBX|44|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|9|N^No^HL70136||||||FOBX|45|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|10|OTH^Other (specify)^NULLFL||||||FOBX|46|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|10|N^No^HL70136||||||FOBX|47|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|11|PHC1878^Other Immunocompromise (not HIV/AIDS)^CDCPHINVS||||||FOBX|48|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|11|N^No^HL70136||||||FOBX|49|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|12|257656006^Resident of Correctional Facility at Diagnostic Evaluation^SCT||||||FOBX|50|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|12|Y^Yes^HL70136||||||FOBX|51|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|13|PHC2099^Resident of Correctional Facility Ever^CDCPHINVS||||||FOBX|52|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|13|Y^Yes^HL70136||||||FOBX|53|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|14|PHC690^TNF Antagonist Therapy^CDCPHINVS||||||FOBX|54|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|14|N^No^HL70136||||||FOBX|55|CWE|INV1117^Patient Epidemiological Risk Factors^PHINQUESTION|15|3738000^Viral hepatitis (any type)^SCT||||||FOBX|56|CWE|INV1118^Patient Epidemiological Risk Factors Indicator^PHINQUESTION|15|UNK^Unknown^NULLFL||||||FOBX|57|CWE|INV1119^Type of Correctional Facility^PHINQUESTION||PHC62^Local Jail^CDCPHINVS||||||FOBX|58|CWE|72166-2^Smoking Status^LN||449868002^Current every day smoker^SCT||||||FOBX|59|CWE|INV1121^Patient lived outside of US for more than 2 months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|60|CWE|INV290^Test Type^PHINQUESTION|1|LAB671^IGRA-QFT^PHINQUESTION||||||FOBX|61|CWE|INV291^Test Result^PHINQUESTION|1|10828004^Positive^SCT||||||FOBX|62|TS|82773-3^Date/Time of Lab Result^LN|1|20171018||||||FOBX|63|TS|68963-8^Specimen Collection Date/Time^LN|1|20171015||||||FOBX|64|CWE|INV290^Test Type^PHINQUESTION|2|20431-3^Smear^LN||||||FOBX|65|CWE|INV291^Test Result^PHINQUESTION|2|260385009^Negative^SCT||||||FOBX|66|CWE|INV290^Test Type^PHINQUESTION|3|50595-8^Pathology^LN||||||FOBX|67|CWE|INV291^Test Result^PHINQUESTION|3|385660001^Not Done^SCT||||||FOBX|68|CWE|INV290^Test Type^PHINQUESTION|4|55277-8^HIV Status^LN||||||FOBX|69|CWE|INV291^Test Result^PHINQUESTION|4|443390004^Refused^SCT||||||FOBX|70|CWE|INV290^Test Type^PHINQUESTION|5|TB119^Tuberculin Skin Test^PHINQUESTION||||||FOBX|71|CWE|INV291^Test Result^PHINQUESTION|5|UNK^Unknown^NULLFL||||||FOBX|72|CWE|INV290^Test Type^PHINQUESTION|6|76629-5^Fasting blood glucose^LN||||||FOBX|73|CWE|INV291^Test Result^PHINQUESTION|6|443390004^Refused^SCT||||||FOBX|74|CWE|INV290^Test Type^PHINQUESTION|7|50941-4^Culture^LN||||||FOBX|75|CWE|INV291^Test Result^PHINQUESTION|7|260385009^Negative^SCT||||||FOBX|76|TS|82773-3^Date/Time of Lab Result^LN|7|20171030||||||FOBX|77|CWE|31208-2^Specimen Source Site^LN|7|119334006^sputum^SCT||||||FOBX|78|TS|68963-8^Specimen Collection Date/Time^LN|7|20171015||||||FOBX|79|CWE|LAB677^Type of Chest Study^PHINQUESTION|1|399208008^Plain Chest X-Ray^SCT||||||FOBX|80|CWE|LAB678^Result of Chest Study^PHINQUESTION|1|PHC1874^Not consistent with TB^CDCPHINVS||||||FOBX|81|CWE|LAB679^Evidence of Cavity^PHINQUESTION|1|N^No^HL70136||||||FOBX|82|CWE|LAB680^Evidence of Miliary TB^PHINQUESTION|1|N^No^HL70136||||||FOBX|83|TS|LAB681^Date of Chest Study^PHINQUESTION|1|20171018||||||FOBX|84|CWE|LAB677^Type of Chest Study^PHINQUESTION|2|169069000^CT Scan^SCT||||||FOBX|85|CWE|LAB678^Result of Chest Study^PHINQUESTION|2|385660001^Not Done^SCT||||||FOBX|86|CWE|INV1274^Case Meets Binational Reporting Criteria^PHINQUESTION||UNK^Unknown^NULLFL||||||FOBX|87|CWE|INV1122^Identified During Contact Investigation^PHINQUESTION||Y^Yes^HL70136||||||FOBX|88|CWE|INV1123^Evaluation During Contact Investigation^PHINQUESTION||Y^Yes^HL70136||||||FOBX|89|ST|INV1124^Linked Case Number^PHINQUESTION||2017GA123123123||||||FOBX|90|DT|86948-7^Date Treatment or Therapy Started^PHINQUESTION||20171020||||||FOBX|91|CWE|55753-8^Treatment Administration Type^LN||435891000124101^DOT (Directly observed therapy, in person)^SCT~PHC1881^EDOT (Electronic DOT, via video call or other electronic method)^CDCPHINVS||||||FOBX|92|CWE|INV1128^Treatment Started^PHINQUESTION||Y^Yes^HL70136||||||FOBX|93|CWE|INV1129^Initial LTBI Drug Regimen^PHINQUESTION||PHC1884^Isoniazid/Rifapentine (3 months; 3HP)^CDCPHINVS||||||FOBX|94|CWE|INV1130^Primary Reason LTBI Treatment Not Started^PHINQUESTION||OTH^Other (specify)^NULLFL^^^^^^originally refused but started treatment||||||FOBX|95|CWE|INV1131^Reason LTBI Treatment Stopped^PHINQUESTION||24484000^Severe Adverse Event^SCT||||||FOBX|96|ST|INV1132^NTSS State Case Number^PHINQUESTION||Did not develop TB||||||FOBX|97|CWE|64750-3^Adverse Event Severity^LN||434081000124108^Hospitalized^SCT||||||F